AAAAAA

   
Results: 1-10 |
Results: 10
NEUROCHEMICAL VARIABLES IN SCHIZOPHRENIC-PATIENTS DURING SWITCHING FROM NEUROLEPTICS TO CLOZAPINE
Authors: HATZIMANOLIS J LYKOURAS L MARKIANOS M OULIS P
Citation: J. Hatzimanolis et al., NEUROCHEMICAL VARIABLES IN SCHIZOPHRENIC-PATIENTS DURING SWITCHING FROM NEUROLEPTICS TO CLOZAPINE, Progress in neuro-psychopharmacology & biological psychiatry, 22(7), 1998, pp. 1077-1085
COMORBIDITY OF DSM-III-R PERSONALITY-DISORDERS IN SCHIZOPHRENIC AND UNIPOLAR MOOD DISORDERS - A COMPARATIVE-STUDY
Authors: OULIS P LYKOURAS L HATZIMANOLIS J TOMARAS V
Citation: P. Oulis et al., COMORBIDITY OF DSM-III-R PERSONALITY-DISORDERS IN SCHIZOPHRENIC AND UNIPOLAR MOOD DISORDERS - A COMPARATIVE-STUDY, European psychiatry, 12(6), 1997, pp. 316-318
ASSOCIATION OF BIOGENIC-AMINE METABOLITES WITH SYMPTOMATOLOGY IN DELUSIONAL, (PSYCHOTIC) AND NONDELUSIONAL DEPRESSED-PATIENTS
Authors: LYKOURAS L MARKIANOS M HATZIMANOLIS J MALLIARAS D STEFANIS C
Citation: L. Lykouras et al., ASSOCIATION OF BIOGENIC-AMINE METABOLITES WITH SYMPTOMATOLOGY IN DELUSIONAL, (PSYCHOTIC) AND NONDELUSIONAL DEPRESSED-PATIENTS, Progress in neuro-psychopharmacology & biological psychiatry, 19(5), 1995, pp. 877-887
PROLACTIN AND CORTISOL RELEASE DURING ECT ARE NOT INFLUENCED BY PRETREATMENT WITH THE SEROTONIN RECEPTOR AGONIST SUMATRIPTAN
Authors: MARKIANOS M LYKOURAS L HATZIMANOLIS J STEFANIS C
Citation: M. Markianos et al., PROLACTIN AND CORTISOL RELEASE DURING ECT ARE NOT INFLUENCED BY PRETREATMENT WITH THE SEROTONIN RECEPTOR AGONIST SUMATRIPTAN, Neuro endocrinology letters, 17(1), 1995, pp. 37-40
PROLACTIN AND TSH RESPONSES TO TRH AND TO HALORERIDOL IN SCHIZOPHRENIC-PATIENTS BEFORE AND AFTER TREATMENT
Authors: MARKIANOS M HATZIMANOLIS J STEFANIS C
Citation: M. Markianos et al., PROLACTIN AND TSH RESPONSES TO TRH AND TO HALORERIDOL IN SCHIZOPHRENIC-PATIENTS BEFORE AND AFTER TREATMENT, European neuropsychopharmacology, 4(4), 1994, pp. 513-516
BIOGENIC-AMINE METABOLITES IN DELUSIONAL (PSYCHOTIC) DEPRESSION AND MELANCHOLIA SUBTYPES OF MAJOR DEPRESSION
Authors: LYKOURAS L MARKIANOS M HATZIMANOLIS J MALLIARAS D STEFANIS C
Citation: L. Lykouras et al., BIOGENIC-AMINE METABOLITES IN DELUSIONAL (PSYCHOTIC) DEPRESSION AND MELANCHOLIA SUBTYPES OF MAJOR DEPRESSION, Progress in neuro-psychopharmacology & biological psychiatry, 18(8), 1994, pp. 1261-1271
EFFECTS OF THE SEROTONIN RECEPTOR AGONIST SUMATRIPTAN, ON HORMONAL PLASMA-LEVELS IN HEALTHY AND DEPRESSED SUBJECTS - A PLACEBO-CONTROLLED STUDY
Authors: MARKIANOS M LYKOURAS L HATZIMANOLIS J BISTOLAKI E
Citation: M. Markianos et al., EFFECTS OF THE SEROTONIN RECEPTOR AGONIST SUMATRIPTAN, ON HORMONAL PLASMA-LEVELS IN HEALTHY AND DEPRESSED SUBJECTS - A PLACEBO-CONTROLLED STUDY, Neuro endocrinology letters, 16(1), 1994, pp. 65-71
EFFECTS OF MONOAMINE-OXIDASE-A INHIBITION ON PLASMA BIOGENIC-AMINE METABOLITES IN DEPRESSED-PATIENTS
Authors: MARKIANOS M ALEVIZOS B HATZIMANOLIS J STEFANIS C
Citation: M. Markianos et al., EFFECTS OF MONOAMINE-OXIDASE-A INHIBITION ON PLASMA BIOGENIC-AMINE METABOLITES IN DEPRESSED-PATIENTS, Psychiatry research, 52(3), 1994, pp. 259-264
CHANGES IN TSH RESPONSES TO TRH AND PLASMA BIOGENIC-AMINE METABOLITESDURING TREATMENT OF DEPRESSED-PATIENTS WITH MOCLOBEMIDE
Authors: MARKIANOS M ALEVIZOS B HATZIMANOLIS J STEFANIS C
Citation: M. Markianos et al., CHANGES IN TSH RESPONSES TO TRH AND PLASMA BIOGENIC-AMINE METABOLITESDURING TREATMENT OF DEPRESSED-PATIENTS WITH MOCLOBEMIDE, Neuro endocrinology letters, 15(3), 1993, pp. 237-242
CLINICAL, ENDOCRINE AND NEUROCHEMICAL EFFECTS OF MOCLOBEMIDE IN DEPRESSED-PATIENTS
Authors: ALEVIZOS B HATZIMANOLIS J MARKIANOS M STEFANIS CN
Citation: B. Alevizos et al., CLINICAL, ENDOCRINE AND NEUROCHEMICAL EFFECTS OF MOCLOBEMIDE IN DEPRESSED-PATIENTS, Acta psychiatrica Scandinavica, 87(4), 1993, pp. 285-290
Risultati: 1-10 |